Surgeon Volume, Prognosis Post-Esophageal Cancer Op Linked

This article originally appeared here.
Share this content:
Surgeon Volume, Prognosis Post-Esophageal Cancer Op Linked
Surgeon Volume, Prognosis Post-Esophageal Cancer Op Linked

(HealthDay News) -- For patients with esophageal cancer undergoing resection, surgeon volume, but not hospital volume, is independently associated with prognosis, according to research published online Jan. 7 in the Journal of Clinical Oncology.

To examine the influence of hospital and surgeon volume on survival after esophageal cancer surgery, Maryam Derogar, M.D., of the Karolinska Institute in Stockholm, and colleagues conducted a population-based cohort study involving 1,335 patients with esophageal cancer who underwent esophageal resection in 1987 to 2005. Participants were followed for survival until February 2011.

The researchers found that annual hospital volume was not independently associated with overall survival, and after adjustment for hospital clustering effects, hospital volume was not associated with short-term mortality. Mortality occurring at least three months after surgery was significantly reduced with a combination of higher annual and cumulative surgeon volume, with a hazard ratio of 0.78 for surgeons with both annual and cumulative volume above versus below the median. The association persisted after adjustment for hospital and surgeon clustering.

"In conclusion, this large and population-based cohort study provided evidence that long-term survival is independently influenced by surgeon volume but not hospital volume," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs